Adverse events32

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 32

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	ABDOMINAL PAIN	Gastrointestinal disorders	FC Participants: Linaclotide 72 μg	1	166	1
other	ABDOMINAL PAIN	Gastrointestinal disorders	FC Participants: Placebo	2	164	2
other	ABDOMINAL PAIN	Gastrointestinal disorders	IBS-C Participants: Linaclotide 145 μg	2	55	2
other	ABDOMINAL PAIN	Gastrointestinal disorders	IBS-C Participants: Linaclotide 290 μg	0	53	0
other	CONSTIPATION	Gastrointestinal disorders	FC Participants: Linaclotide 72 μg	1	166	1
other	CONSTIPATION	Gastrointestinal disorders	FC Participants: Placebo	0	164	0
other	CONSTIPATION	Gastrointestinal disorders	IBS-C Participants: Linaclotide 145 μg	2	55	2
other	CONSTIPATION	Gastrointestinal disorders	IBS-C Participants: Linaclotide 290 μg	0	53	0
other	DIARRHOEA	Gastrointestinal disorders	FC Participants: Linaclotide 72 μg	6	166	6
other	DIARRHOEA	Gastrointestinal disorders	FC Participants: Placebo	3	164	3
other	DIARRHOEA	Gastrointestinal disorders	IBS-C Participants: Linaclotide 145 μg	4	55	4
other	DIARRHOEA	Gastrointestinal disorders	IBS-C Participants: Linaclotide 290 μg	4	53	4
other	COVID-19	Infections and infestations	FC Participants: Linaclotide 72 μg	4	166	4
other	COVID-19	Infections and infestations	FC Participants: Placebo	5	164	5
other	COVID-19	Infections and infestations	IBS-C Participants: Linaclotide 145 μg	2	55	2
other	COVID-19	Infections and infestations	IBS-C Participants: Linaclotide 290 μg	1	53	1
serious	DIARRHOEA	Gastrointestinal disorders	FC Participants: Linaclotide 72 μg	1	166	1
serious	DIARRHOEA	Gastrointestinal disorders	FC Participants: Placebo	0	164	0
serious	DIARRHOEA	Gastrointestinal disorders	IBS-C Participants: Linaclotide 145 μg	0	55	0
serious	DIARRHOEA	Gastrointestinal disorders	IBS-C Participants: Linaclotide 290 μg	0	53	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04026113/events

API reference For AI assistants

Adverse events32

Sources 3

Read this list from software.